Phase II Study of Proton Radiotherapy for Spine and Paraspinal Sarcoma

Reviewer: John P. Plastaras, MD, PhD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 9 de noviembre del 2006

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Pazopanib Active in Metastatic Soft-Tissue Sarcoma

May 17, 2012

Progression-free survival up in metastatic non-adipocyte soft-tissue sarcoma, after chemo

New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials

Nov 25, 2015

Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily

ASTRO: Radiotherapy Improves Dysphagia in Esophageal Cancer

Sep 17, 2014

Similar improvement in dysphagia for radiotherapy alone, chemoradiotherapy